View in EDS PDF Full Text

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

Saved in:
Bibliographic Details
Title: Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
Authors: Timmins JM; Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA., Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, Smith TL, Hayden MR, Maeda N, Parks JS
Source: The Journal of clinical investigation [J Clin Invest] 2005 May; Vol. 115 (5), pp. 1333-42. Date of Electronic Publication: 2005 Apr 07.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0021-9738 (Print) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 15841208
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Timmins+JM%22">Timmins JM</searchLink>; Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.<br /><searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink><br /><searchLink fieldCode="AU" term="%22Boudyguina+E%22">Boudyguina E</searchLink><br /><searchLink fieldCode="AU" term="%22Kluckman+KD%22">Kluckman KD</searchLink><br /><searchLink fieldCode="AU" term="%22Brunham+LR%22">Brunham LR</searchLink><br /><searchLink fieldCode="AU" term="%22Mulya+A%22">Mulya A</searchLink><br /><searchLink fieldCode="AU" term="%22Gebre+AK%22">Gebre AK</searchLink><br /><searchLink fieldCode="AU" term="%22Coutinho+JM%22">Coutinho JM</searchLink><br /><searchLink fieldCode="AU" term="%22Colvin+PL%22">Colvin PL</searchLink><br /><searchLink fieldCode="AU" term="%22Smith+TL%22">Smith TL</searchLink><br /><searchLink fieldCode="AU" term="%22Hayden+MR%22">Hayden MR</searchLink><br /><searchLink fieldCode="AU" term="%22Maeda+N%22">Maeda N</searchLink><br /><searchLink fieldCode="AU" term="%22Parks+JS%22">Parks JS</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2005 May; Vol. 115 (5), pp. 1333-42. <i>Date of Electronic Publication: </i>2005 Apr 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0021-9738 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=15841208
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI23915
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1333
    Titles:
      – TitleFull: Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Timmins JM
      – PersonEntity:
          Name:
            NameFull: Lee JY
      – PersonEntity:
          Name:
            NameFull: Boudyguina E
      – PersonEntity:
          Name:
            NameFull: Kluckman KD
      – PersonEntity:
          Name:
            NameFull: Brunham LR
      – PersonEntity:
          Name:
            NameFull: Mulya A
      – PersonEntity:
          Name:
            NameFull: Gebre AK
      – PersonEntity:
          Name:
            NameFull: Coutinho JM
      – PersonEntity:
          Name:
            NameFull: Colvin PL
      – PersonEntity:
          Name:
            NameFull: Smith TL
      – PersonEntity:
          Name:
            NameFull: Hayden MR
      – PersonEntity:
          Name:
            NameFull: Maeda N
      – PersonEntity:
          Name:
            NameFull: Parks JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2005 May
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 0021-9738
          Numbering:
            – Type: volume
              Value: 115
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1